1. Home
  2. RYTM vs CAG Comparison

RYTM vs CAG Comparison

Compare RYTM & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$102.60

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$14.76

Market Cap

6.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
CAG
Founded
2008
1919
Country
United States
United States
Employees
N/A
26100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.9B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
RYTM
CAG
Price
$102.60
$14.76
Analyst Decision
Strong Buy
Hold
Analyst Count
14
17
Target Price
$131.14
$16.88
AVG Volume (30 Days)
646.7K
14.6M
Earning Date
05-05-2026
04-01-2026
Dividend Yield
N/A
9.84%
EPS Growth
28.34
N/A
EPS
N/A
N/A
Revenue
N/A
$1,500,000,000.00
Revenue This Year
$55.34
N/A
Revenue Next Year
$86.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$74.50
$12.53
52 Week High
$122.20
$20.32

Technical Indicators

Market Signals
Indicator
RYTM
CAG
Relative Strength Index (RSI) 46.08 58.71
Support Level $98.30 $13.66
Resistance Level $113.51 $16.07
Average True Range (ATR) 3.76 0.54
MACD -1.65 0.06
Stochastic Oscillator 11.09 71.39

Price Performance

Historical Comparison
RYTM
CAG

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About CAG ConAgra Brands Inc.

Conagra Brands Inc is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). The majority of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company sells through the USA retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

Share on Social Networks: